|
1
|
Chhikara BS and Parang K: Global cancer
statistics 2022: The trends projection analysis. Chem Biol Lett.
10:4512023.
|
|
2
|
Bourreille J, Metayer P, Sauger F, Matray
F and Fondimare A: Existence of alpha-fetoprotein during
gastric-origin secondary cancer of the liver. Presse Med (1893).
78:1277–1278. 1970.(In French). PubMed/NCBI
|
|
3
|
Daniele B, Bencivenga A, Megna AS and
Tinessa V: Alpha-fetoprotein and ultrasonography screening for
hepatocellular carcinoma. Gastroenterology. 127 (5 Suppl
1):S108–S112. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Conor GT, Tatarinov YS, Abelev GI and
Uriel J: A collaborative study for the evaluation of a serologic
test for primary liver cancer. Cancer. 25:1091–1098. 1970.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Babalı A, Çakal E, Purnak T, Bıyıkoğlu I,
Cakal B, Yüksel O and Köklü S: Serum α-fetoprotein levels in liver
steatosis. Hepatol Int. 3:551–555. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Motoyama T, Watanabe H, Yamamoto T and
Sekiguchi M: Production of alpha-fetoprotein by human germ cell
tumors in vivo and in vitro. Acta Pathol Jpn. 37:1263–1277.
1987.PubMed/NCBI
|
|
7
|
Ezaki T, Yukaya H, Ogawa Y, Chang YC and
Nagasue N: Elevation of alpha-fetoprotein level without evidence of
recurrence after hepatectomy for hepatocellular carcinoma. Cancer.
61:1880–1883. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ganjei P, Nadji M, Albores-Saavedra J and
Morales AR: Histologic markers in primary and metastatic tumors of
the liver. Cancer. 62:1994–1998. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yasunami R, Hashimoto Z, Ogura T, Hirao F
and Yamamura Y: Primary lung cancer producing alpha-fetoprotein: A
case report. Cancer. 47:926–929. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saito S, Hatano T, Hayakawa M, Koyama Y,
Ohsawa A and Iwamasa T: Studies on alpha-fetoprotein produced by
renal cell carcinoma. Cancer. 63:544–549. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamagata T, Yamagata Y, Nakanishi M,
Matsunaga K, Minakata Y and Ichinose M: A case of primary lung
cancer producing alpha-fetoprotein. Can Respir J. 11:504–506. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsueda K, Yamamoto H, Yoshida Y and
Notohara K: Hepatoid carcinoma of the pancreas producing protein
induced by vitamin K absence or antagonist II (PIVKA-II) and
alpha-fetoprotein (AFP). J Gastroenterol. 41:1011–1019. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Itoh T, Kishi K, Tojo M, Kitajima N,
Kinoshita Y, Inatome T, Fukuzaki H, Nishiyama N, Tachibana H and
Takahashi H: Acinar cell carcinoma of the pancreas with elevated
serum alpha-fetoprotein levels: A case report and a review of 28
cases reported in Japan. Gastroenterol Jpn. 27:785–791. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kato K, Matsuda M, Ingu A, Imai M, Kasai
S, Mito M and Kobayashi T: Colon cancer with a high serum
alpha-fetoprotein level. Am J Gastroenterol. 91:1045–1046.
1996.PubMed/NCBI
|
|
15
|
Yachida S, Fukushima N, Nakanishi Y, Akasu
T, Kitamura H, Sakamoto M and Shimoda T:
Alpha-fetoprotein-producing carcinoma of the colon: Report of a
case and review of the literature. Dis Colon Rectum. 46:826–831.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kinjo T, Taniguchi H, Kushima R, Sekine S,
Oda I, Saka M, Gotoda T, Kinjo F, Fujita J and Shimoda T:
Histologic and immunohistochemical analyses of
α-fetoprotein-producing cancer of the stomach. Am J Surg Pathol.
36:56–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu X, Cheng Y, Sheng W, Lu H, Xu Y, Long
Z, Zhu H and Wang Y: Clinicopathologic features and prognostic
factors in alpha-fetoprotein-producing gastric cancers: Analysis of
104 cases. J Surg Oncol. 102:249–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagai E, Ueyama T, Yao T and Tsuneyoshi M:
Hepatoid adenocarcinoma of the stomach. A clinicopathologic and
immunohistochemical analysis. Cancer. 72:1827–1835. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang D, Li C, Xu Y, Xing Y, Qu L, Guo Y,
Zhang Y, Sun X and Suo J: Clinicopathological characteristics and
prognosis of alpha-fetoprotein positive gastric cancer in Chinese
patients. Int J Clin Exp Pathol. 8:6345–6355. 2015.PubMed/NCBI
|
|
20
|
Hirajima S, Komatsu S, Ichikawa D, Kubota
T, Okamoto K, Shiozaki A, Fujiwara H, Konishi H, Ikoma H and Otsuji
E: Liver metastasis is the only independent prognostic factor in
AFP-producing gastric cancer. World J Gastroenterol. 19:6055–6061.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kono K, Amemiya H, Sekikawa T, Iizuka H,
Takahashi A, Fujii H and Matsumoto Y: Clinicopathologic features of
gastric cancers producing alpha-fetoprotein. Dig Surg. 19:359–365.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang YC, Nagasue N, Abe S, Taniura H,
Kumar DD and Nakamura T: Comparison between the clinicopathologic
features of AFP-positive and AFP-negative gastric cancers. Am J
Gastroenterol. 87:321–325. 1992.PubMed/NCBI
|
|
23
|
Sun N, Sun Q, Liu Q, Zhang T, Zhu Q, Wang
W, Cao M and Zang QI: α-fetoprotein-producing gastric carcinoma: A
case report of a rare subtype and literature review. Oncol Lett.
11:3101–3104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ishikura H, Fukasawa Y, Ogasawara K,
Natori T, Tsukada Y and Aizawa M: An AFP-producing gastric
carcinoma with features of hepatic differentiation. A case report.
Cancer. 56:840–848. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ishikura H, Kirimoto K, Shamoto M,
Miyamoto Y, Yamagiwa H, Itoh T and Aizawa M: Hepatoid
adenocarcinomas of the stomach. An analysis of seven cases. Cancer.
58:119–126. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin JX, Wang ZK, Hong QQ, Zhang P, Zhang
ZZ, He L, Wang Q, Shang L, Wang LJ, Sun YF, et al: Assessment of
clinicopathological characteristics and development of an
individualized prognostic model for patients with hepatoid
adenocarcinoma of the stomach. JAMA Netw Open. 4:e21282172021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi J, Liu L and Chen YP: Research
progress of prognostic analysis and clinicopathological
characteristics of hepatoid adenocarcinoma of the stomach. Zhonghua
Zhong Liu Za Zhi. 43:104–107. 2021.(In Chinese). PubMed/NCBI
|
|
28
|
Machlowska J, Baj J, Sitarz M, Maciejewski
R and Sitarz R: Gastric cancer: Epidemiology, risk factors,
classification, genomic characteristics and treatment strategies.
Int J Mol Sci. 21:40122020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang FH, Zhang XT, Tang L, Wu Q, Cai MY,
Li YF, Qu XJ, Qiu H, Zhang YJ, Ying JE, et al: The Chinese society
of clinical oncology (CSCO): Clinical guidelines for the diagnosis
and treatment of gastric cancer, 2023. Cancer Commun (Lond).
44:127–172. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
WHO Classification of Tumours Editorial
Board, . WHO classification of tumours. Digestive System Tumours.
5th edition. World Health Organization; Lyon: 2019
|
|
31
|
Amin MB, Edge SB, Greene FL and Brierley
JD: AJCC cancer staging manual. 8th edition. Springer; New York,
NY: 2017
|
|
32
|
Kodama T, Kameya T, Hirota T, Shimosato Y,
Ohkura H, Mukojima T and Kitaoka H: Production of
alpha-fetoprotein, normal serum proteins, and human chorionic
gonadotropin in stomach cancer: Histologic and immunohistochemical
analyses of 35 cases. Cancer. 48:1647–1655. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chinese Medical Association Oncology, .
Clinical diagnosis and treatment guideline of gastric cancer of
Chinese Medical Association (2021 edition). Natl Med J Chin.
102:1169–1189. 2022.(In Chinese).
|
|
34
|
Sun L, Wei JJ, An R, Cai HY, Lv Y, Li T,
Shen XF, Du JF and Chen G: Gastric adenosquamous carcinoma with an
elevated serum level of alpha-fetoprotein: A case report. World J
Gastrointest Surg. 15:2357–2361. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Trompetas V, Varsamidakis N, Frangia K,
Polimeropoulos V and Kalokairinos E: Gastric hepatoid
adenocarcinoma and familial investigation: Does it always produce
alpha-fetoprotein? Eur J Gastroenterol Hepatol. 15:1241–1244. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiao XH, Dong LC, Tian GL, Zheng YY and
Shao YY: 2 cases of alpha-fetoprotein-elevated gastric cancer and
literature review. J Qiqihar Med Univ. 23:1752010.(In Chinese).
|
|
37
|
Motoyama T, Aizawa K, Watanabe H, Fukase M
and Saito K: Alpha-fetoprotein producing gastric carcinomas: A
comparative study of three different subtypes. Acta Pathol Jpn.
43:654–661. 1993.PubMed/NCBI
|
|
38
|
Yang XS, Wang AQ, Wu Y, Li Z, Bu Z and Ji
J: Hepatoid adenocarcinoma of stomach: Current research, progress,
and controversy. Chin J Clin Oncol. 50:679–684. 2023.(In
Chinese).
|
|
39
|
Chen EB, Wei YC, Liu HN, Tang C, Liu ML,
Peng K and Liu T: Hepatoid adenocarcinoma of stomach: Emphasis on
the clinical relationship with alpha-fetoprotein-positive gastric
cancer. Biomed Res Int. 2019:67104282019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen Y, Qu H, Jian M, Sun G and He Q: High
level of serum AFP is an independent negative prognostic factor in
gastric cancer. Int J Biol Markers. 30:e387–e393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin HJ, Hsieh YH, Fang WL, Huang KH and Li
AF: Clinical manifestations in patients with
alpha-fetoprotein-producing gastric cancer. Curr Oncol.
21:e394–e399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ooi A, Nakanishi I, Sakamoto N, Tsukada Y,
Takahashi Y, Minamoto T and Mai M: Alpha-fetoprotein
(AFP)-producing gastric carcinoma. Is it hepatoid differentiation?
Cancer. 65:1741–1747. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gong W, Shou D and Gong P: Extremely high
expression of serum alpha-fetoprotein level of gastric
adenocarcinoma: A rare case with an unexpected well-prognosis.
Springerplus. 5:20562016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu J, Kane S, Wu J, Benedettini E, Li D,
Reeves C, Innocenti G, Wetzel R, Crosby K, Becker A, et al:
Mutation-specific antibodies for the detection of EGFR mutations in
non-small-cell lung cancer. Clin Cancer Res. 15:3023–3028. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Simonetti S, Molina MA, Queralt C, de
Aguirre I, Mayo C, Bertran-Alamillo J, Sanchez JJ, Gonzalez-Larriba
JL, Jimenez U, Isla D, et al: Detection of EGFR mutations with
mutation-specific antibodies in stage IV non-small-cell lung
cancer. J Transl Med. 8:1352010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hofman P, Ilie M, Hofman V, Roux S, Valent
A, Bernheim A, Alifano M, Leroy-Ladurie F, Vaylet F, Rouquette I,
et al: Immunohistochemistry to identify EGFR mutations or ALK
rearrangements in patients with lung adenocarcinoma. Ann Oncol.
23:1738–1743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Guo R, Ma L, Bai X, Miao L, Li Z and Yang
J: A scoring method for immunohistochemical staining on Ki67. Appl
Immunohistochem Mol Morphol. 29:e20–e28. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li XD, Wu CP, Ji M, Wu J, Lu B, Shi HB and
Jiang JT: Characteristic analysis of α-fetoprotein-producing
gastric carcinoma in China. World J Surg Oncol. 11:2462013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Su JS, Chen YT, Wang RC, Wu CY, Lee SW and
Lee TY: Clinicopathological characteristics in the differential
diagnosis of hepatoid adenocarcinoma: A literature review. World J
Gastroenterol. 19:321–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiang J, Ding Y, Lu J, Chen Y, Chen Y,
Zhao W, Chen W, Kong M, Li C, Teng X, et al: Integrative analysis
reveals a clinicogenomic landscape associated with liver metastasis
and poor prognosis in hepatoid adenocarcinoma of the stomach. Int J
Biol Sci. 18:5554–5574. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lu J, Ding Y, Chen Y, Jiang J, Chen Y,
Huang Y, Wu M, Li C, Kong M, Zhao W, et al: Whole-exome sequencing
of alpha-fetoprotein producing gastric carcinoma reveals genomic
profile and therapeutic targets. Nat Commun. 12:39462021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Crowe SE: Helicobacter pylori infection. N
Engl J Med. 380:1158–1165. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bornschein J, Selgrad M, Warnecke M,
Kuester D, Wex T and Malfertheiner P: H. pylori infection is a key
risk factor for proximal gastric cancer. Dig Dis Sci. 55:3124–3131.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kumar S, Metz DC, Ellenberg S, Kaplan DE
and Goldberg DS: Risk factors and incidence of gastric cancer after
detection of Helicobacter pylori infection: A large cohort study.
Gastroenterology. 158:527–536.e7. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shirani M, Pakzad R, Haddadi MH, Akrami S,
Asadi A, Kazemian H, Moradi M, Kaviar VH, Zomorodi AR, Khoshnood S,
et al: The global prevalence of gastric cancer in Helicobacter
pylori-infected individuals: A systematic review and meta-analysis.
BMC Infect Dis. 23:5432023. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Alipour M: Molecular mechanism of
Helicobacter pylori-induced gastric cancer. J Gastrointest Cancer.
52:23–30. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Takahashi-Kanemitsu A, Lu MX, Knight CT,
Yamamoto T, Hayash T, Mii Y, Ooki T, Kikuchi I, Kikuchi A, Barker
N, et al: The Helicobacter pylori CagA oncoprotein disrupts Wnt/PCP
signaling and promotes hyperproliferation of pyloric gland base
cells. Sci Signal. 16:eabp90202023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu DR, Li BB, Yan B, Liu L, Jia Y, Wang
Y, Ma X and Yang F: The clinicopathological features and prognosis
of serum AFP positive gastric cancer: A report of 16 cases. Int J
Clin Exp Pathol. 13:2439–2446. 2020.PubMed/NCBI
|
|
59
|
Ge Z, Ben Q, Qian J, Wang Y and Li Y:
Diabetes mellitus and risk of gastric cancer: A systematic review
and meta-analysis of observational studies. Eur J Gastroenterol
Hepatol. 23:1127–1135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yoon JM, Son KY, Eom CS, Durrance D and
Park SM: Pre-existing diabetes mellitus increases the risk of
gastric cancer: A meta-analysis. World J Gastroenterol. 19:936–945.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sekikawa A, Fukui H, Maruo T, Tsumura T,
Okabe Y and Osaki Y: Diabetes mellitus increases the risk of early
gastric cancer development. Eur J Cancer. 50:2065–2071. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Bae JM: Diabetes history and gastric
cancer risk: Different results by types of follow-up studies. Asian
Pac J Cancer Prev. 23:1523–1528. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Dabo B, Pelucchi C, Rota M, Jain H,
Bertuccio P, Bonzi R, Palli D, Ferraroni M, Zhang ZF,
Sanchez-Anguiano A, et al: The association between diabetes and
gastric cancer: Results from the stomach cancer pooling project
consortium. Eur J Cancer Prev. 31:260–269. 2022. View Article : Google Scholar : PubMed/NCBI
|
